NoBACZ Healthcare launches Ambugreen – a new, waterproof and antibiotic-free gel barrier
Ambugreen is a ground-breaking gel barrier that features unique patented technology.
Momentum Bioscience Moves To Milton Park To Develop Time Critical Sepsis Tests
Momentum Bioscience, a biotech company pioneering rapid sepsis diagnostics, has relocated to Oxfordshire’s Milton Park, the UK’s largest single-ownership innovation community.
Qureight and Remedy Cell to validate RC-0315 in Phase Ib trial for IPF
Qureight will integrate its deep-learning technology into the study, providing imaging core lab services.
Dogtooth appoints Jorge Heraud as chairman
Robotic harvesting specialist appoints Blue River Technology co-founder as new chairman of the board.
Sphere Fluidics rebrands to Sphere Bio
Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.
Monument Therapeutics secures £850K to advance schizophrenia treatment with MT1988
Neuroscience startup Monument Therapeutics has developed MT1988, a novel fixed-dose combination drug for the cognitive impairment associated with schizophrenia.
Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial
Nearly 20 subjects in the US are being enrolled for the trial.
Oxford Drug Design awarded £1m to progress uUTI treatment
Oxford Drug Design has been awarded £1 ($1.2) million in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme from PACE (Pathways to Antimicrobial Clinical Efficacy).
FLIT to ramp up electric bike production as investors pump in £1.2m
Cambridge-based FLIT, an engineering company that builds folding electric bikes for urban commuters, has raised £1.2 million in new funding. The cash injection will be used to scale up production of its latest model, the FLIT M2 at the company’s Cambridge facility.
Atelerix raises £750,000 in venture funding
The Newcastle University spinout will use the funds to develop the company’s sales and drive widespread adoption of its biological transport technology.
Wazoku and MAPEGY agree partnership to bring smarter and faster market intelligence for innovation
Anglo / German partnership harnesses AI to redefine market intelligence for total innovation
Qureight and Avalyn launch strategic partnership in progressive pulmonary fibrosis
Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat life-threatening pulmonary diseases, have announced the initiation of a strategic partnership in progressive pulmonary fibrosis.
Fresh4Cast adds AI-powered reports to its offer
Forecasting and planning specialist now provides its Control Tower customers with tailored reports summarising their data on demand, sales, operations and crop availability
Paragraf and the University of Cambridge Receive Innovate UK Grant for Graphene Memory Device Initiative
Paragraf, a UK-based company leading the way in mass-producing graphene-based electronics using standard semiconductor processes, has been awarded a £419,419 grant from Innovate UK.
Albotherm’s CTO Dr Siân Fussell Wins Prestigious Innovate UK Women in Innovation Award
Dr Siân Fussell, CTO and co-founder of Bristol-based Albotherm, has been named one of the 50 winners of the Innovate UK Women in Innovation Awards 2025.
Kidney Research UK invests in Healthinote patient education platform which could support >15m people with long term health conditions
Kidney Research UK, the leading charity dedicated to kidney health, has made a significant investment in Cognitant Group Ltd, a leading provider of digital education and support tools to improve the management of long-term health conditions.
Isomerase and BugBiome partner for agriculture innovation
Isomerase has formed a strategic partnership with fellow Cambridge business BugBiome focused on the discovery of novel targeted bioinsecticides via insect behavioural screening.
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Promising results from mouse study lead to expanded trials.
New CEO drives ieso Digital Health towards glory in the US
ieso Digital Health, a Cambridge-based leader in digital mental healthcare, has appointed a new CEO to steer commercialisation of its products in the United States.
University of Birmingham and Paragraf Partner to Develop Graphene Sensors for Quantum Computing
The University of Birmingham has partnered with Paragraf, a UK-based graphene technology company, to explore the potential of graphene sensors in quantum computing.